Oxford Brain Diagnostics (OBD) is preparing to launch its groundbreaking technology for the early diagnosis of dementia across the UK and US healthcare markets, following a wave of key regulatory approvals that mark a major milestone in the company’s growth. Backed by growth capital investor BGF, the Oxford-based medtech firmContinue Reading

The UK government has announced a major step forward in its international artificial intelligence strategy, unveiling plans for a new UK-EU collaboration that could deliver breakthroughs in healthcare, energy and advanced technologies, while boosting British jobs and economic growth. From today, UK public research organisations can apply to host theContinue Reading